Chandigarh: The Narcotics Control Bureau has intensified its crackdown on a sprawling drug-diversion network, issuing non-bailable warrants against the proprietors of Digital Vision, a pharmaceutical manufacturer based in Kala Amb. The action marks a significant escalation in the investigation into what officials describe as one of the largest illegal pharma supply chains uncovered in recent years.
Those named in the warrants—Parshotam Lal Goyal and his sons, Konic and Manic Goyal, all residents of Ambala—are accused of steering a covert operation that funnelled psychotropic medicines and controlled substances into multiple states using falsified documentation and shell distributors.
Digital Vision first drew the agency’s attention after the arrest of its partner, Anuj Kumar, on November 1. His interrogation reportedly opened the trail to a larger network, prompting the NCB’s Special Investigation Team to carry out a series of raids over the past several weeks.
During these searches, investigators confiscated a staggering quantity of prohibited pharmaceutical material, including over 611 kilograms of psychotropic powder, 573 kilograms of tramadol mixture, roughly 12 lakh tablets containing controlled substances, as well as tens of thousands of injectable ampoules and vials. With this latest haul, total seizures in the case have climbed to more than 34 lakh tablets, over 10 lakh bottles of codeine-based cough syrup, and over 2,000 kilograms of raw materials—an inventory that officers estimate to be worth nearly Rs 600 crore on the illegal market. Fifteen individuals have been arrested so far.
According to NCB officials, Digital Vision served as the principal manufacturing base for the unlawful operation. The firm is believed to have supplied enormous quantities of tramadol capsules and codeine phosphate formulations to purported distributors in Jodhpur and Dehradun—entities that investigators say were nothing more than paper fronts created to mask the movement of drugs across state borders.
The company is not new to controversy. In 2020, it came under heavy scrutiny after one of its cough syrup batches was associated with the deaths of a dozen infants in Udhampur, raising longstanding questions about its compliance and oversight practices.
With warrants now issued for the Goyal family, the NCB is pressing forward to dismantle the remaining links in the distribution chain, calling the case a major blow to illegal pharmaceutical trafficking networks operating under the guise of legitimate manufacturing.
